September 30, 2026 at 11:05 AM UTC
Connect Biopharma Holdings Ltd issues Regulation FD disclosure
Connect Biopharma Holdings Ltd filed an 8-K covering a Regulation FD disclosure and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 30, 2026 at 11:05 AM UTC
Open official source